Director | Office of Health Economics
Secretary General | European Patients Forum (EPF), Brussels, Belgium
Felix Lobo, PhD
Emeritus Professor of Economics | University Carlos III de Madrid, Madrid, Spain
Managing Director, Science & Policy Consultancy. Professor in Health Services Research and HTA at Department of Public Health Research Unit of User Perspectives, | University of Southern Denmark, and External Lecturer at Copenhagen Business School, Department of Strategy and Innovation, Denmark
Director, Health Systems, Medical Products and Innovation, Directorate General | Health and Food Safety (DG SANTE), European Commission, Belgium
Head, HTA & Payment Policy, Global Pricing & Market Access (GPMA) | F. Hoffmann-La Roche AG, Basel, Switzerland
Eric Low, OBE
Head of Global Strategy | Amyloidosis Research Consortium, East Lothian, Scotland, UK
Geert van Maanen
Former Secretary-General | Ministry of Health, Welfare and Sport, The Netherlands
Guillem López-Casasnovas, PhD
Professor | Department of Economics and Founder & Director, Center for Health and Economics, Universitat Pompeu Fabra, Barcelona, Spain
Chief Financial Officer | PureTech Health, Boston, MA, USA
Lluis Sauri-Romero
Economist | DG Competition, European Commission, Brussels, Belgium
Chair | EUnetHTA JA3 Plenary Assembly and Senior Researcher, Regional Agency for Health (ASSR), Emilia Romagna, Italy
Head, Department of Pharmacoeconomics, Institute of Mother and Child, and Business School, Warsaw University of Technology, Warsaw, Poland | Former Undersecretary of State/Vice Minister, Polish Ministry of Health, Poland
Menno Aarnout
Executive Director | International Association of Mutual Benefit Societies (AIM), Brussels, Belgium
Peter C. Smith, MSc
Emeritus Professor of Health Policy | Imperial College Business School and Professor of Global Health Economics, Centre for Health Economics, University of York, London, UK
Richard Torbett, PhD
Executive Director | Commercial Policy - UK and International, The Association of the British Pharmaceutical Industry (ABPI) and Chair, Pricing & Reimbursement Priority Working Group, EFPIA, London, UK
Roman Topór-Mądry
President | Agency for Health Technology Assessment at Tariff System (AOTMiT), Warsaw, Poland
Sarah Garner, PhD
Coordinator | Innovation, Access and Use, Essential Medicines and Health Products Department, World Health Organization (WHO), Geneva, Switzerland
Director | Policy and Economic Analysis, Patented Medicine Prices Review Board (PMPRB), Government of Canada, Ottawa, Canada
Director of Research | Office of Health Economics
Director, Patient Engagement | Arthritis Foundation
Research Scientist | Google
Research Programme Officer | EU Policies, Unit H3, eHealth, Well-being & Ageing, DG CONNECT, Communications Networks, Content and Technology, European Commission, Brussels, Belgium
Global Head of Strategy, Innovation and Technology, Health Business Unit | Wipro Limited, New York, NY, USA
Clinical Data Scientist | Erasmus University Medical Centre, Rotterdam, Associate Dean, Permanent Education for Professionals, Jheronimus Academy of Data Science, Rotterdam, The Netherlands
Co-Founder, CML Advocates Network and Founder and CEO, Patvocates, EUPATI, Munich, Germany |
Vice President, Real-World & Late Phase | Syneos Health, Toronto, Canada
Head of Sector, HTA, Directorate General | Health and Food Safety (DG SANTE), European Commission
.jpg?sfvrsn=785321a1_0 "Bedlington_Nicola (3)")
